In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using 19F magnetic resonance spectroscopy

International Journal of Radiation Biology

Volumn 84, Issue 3, 2008, Pages 237-242

  Hoff, Michael N ^a   Yapp, Donald T ^b   Yung, Andrew C ^a   Oliver, Thomas S ^b   Kozlowski, Piotr ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c VANCOUVER PROSTATE CENTRE   (Canada)

Author keywords

2 nitroimidazole binding; 19F magnetic resonance spectroscopy; Hypoxia probes; Shionogi tumour model

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE;

ANIMAL CELL; ARTICLE; CANCER MODEL; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORINE NUCLEAR MAGNETIC RESONANCE; HYPOXIA; MEASUREMENT; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL DETECTION;

ANIMALS; CELL HYPOXIA; DISEASE MODELS, ANIMAL; ETANIDAZOLE; FEMALE; FLUORINE RADIOISOTOPES; HYDROCARBONS, FLUORINATED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS;

MUS; SOLENOIDEA;

EID: 40049083087     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000801902174     Document Type: Article

References (27)

1. Aboagye EO, Lewis AD, Johnson A, Workman P, Tracy M, Huxham IM. 1995. The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: Reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis. British Journal of Cancer 72:312-318.
2. Aboagye EO, Maxwell RJ, Kelson AB, Tracy M, Lewis AD, Graham MA, Horsman MR, Griffiths JR, Workman P. 1997. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia. Cancer Research 57:3314-3318.
3. Chapman JD, Franko AJ, Sharplin J. 1981. A marker for hypoxic cells in tumours with potential clinical applicability. British Journal of Cancer 43:546-550.
4. Chapman JD, Baer K, Lee J. 1983. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Research 43:1523-1528.
5. Clark LC Jr, Wolf R, Granger D, Taylor Z. 1953. Continuous recording of blood oxygen tensions by polarography. Journal of Applied Physiology 6:189-193.
6. Gray LH, Conger AD, Ebert M, Hornsey, Scott OC. 1953. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. British Journal of Radiology 26:638-648.
7. Hodgkiss RJ. 1998. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia. Anti-Cancer Drug Design 13:687-702.
8. Jeffrey FM, Storey CJ, Nunnally RL, Malloy CR. 1989. Effect of ischemia on NMR detection of phosphorylated metabolites in the intact rat heart. Biochemistry 28:5323-5326.
9. Kolstad P. 1968. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scandinavian Journal of Clinical & Laboratory Investigation 106:145-157.
10. 19F magnetic resonance spectroscopy and immunohistochemistry. Radiation Research 129:71-78.
11. Laughlin KM, Evans SM, Jenkins WT, Tracy M, Chan CY, Lord EM, Koch CJ. 1996. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N- (2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. Journal of Pharmacology and Experimental Therapeutics 277:1049-1057.
12. Lord EM, Harwell L, Koch CJ. 1993. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Research 53:5721-5726.
13. Milross CG, Peters LJ, Hunter NR, Mason KA, Tucker SL, Milas L. 1996. Polarographic pO2 measurement in mice: effect of tumor type, site of implantation, and anaesthesia. Radiation Oncology Investigations 4:108-114.
14. Minesita T, Yamaguchi K. 1965. An androgen-dependent mouse mammary tumor. Cancer Research 25:1168-1175.
15. Mottram JC. 1936. Factor of importance in the radiosensitivity of tumours. British Journal of Radiology 9:606-614.
16. 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors. Clinical Cancer Research 13:3738-3747.
17. Raleigh JA, Franko AJ, Treiber EO, Lunt JA, Allen PS. 1986. Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice: Detection by F-19 nuclear magnetic resonance at 2.35 T. International Journal of Radiatian Oncology, Biology and Physics 12:1243-1245.
18. Raleigh JA, Koch CJ. 1990. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochemical Pharmacology 40:2457-2464.
19. Rasey JS, Grunbaum Z, Magee S, Nelson NJ, Olive PL, Durand RE, Krohn KA. 1987. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiation Research 111:292-304.
20. 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia. Philosophical Transactions of the Royal Society of London, Series B 359:987-996.
21. 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors. Radiotherapy and Oncology 73:359-366.
22. Seddon BM, Maxwell RJ, Honess DJ, Grimshaw R, Raynaud F, Tozer GM, Workman P. 2002. Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopy. Clinical Cancer Research 8:2323-2335.
23. Silver ARJ, McNeil SS, O'Neill P, Jenkins TC, Ahmed I. 1986. Induction of DNA strand breaks by reduced nitroimidazoles: Implications for DNA base damage. Biochemical Pharmacology 35:3923-3928.
24. Skov K, Adomat H, Bowden M, Dragowska W, Gleave M, Koch CJ, Woo J, Yapp DT. 2004. Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages. Radiation Research 162:547-553.
25. Vanhamme L, van den Boogaart A, Van Huffel S. 1997. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. Journal of Magnetic Resonance 129:35-43.
26. Varghese AJ, Whitmore GF. 1980. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole. Cancer Research 40:2165-2169.
27. Varghese AJ. 1983. Glutathione conjugates of misonidazole. Biochemical and Biophysical Research Communications 112:1013-1020.